Christopher Aker

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Aker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Aker:

Company Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Sr. VP & General Counsel Common Stock 0 $0 $7.87 25 Jun 2025 Direct
Regulus Therapeutics Inc. Sr. VP & General Counsel Stock Option (Right to Buy) 487,500 30 Jan 2025 Direct
Regulus Therapeutics Inc. Sr. VP & General Counsel Stock Option 0 25 Jun 2025 Direct

Insider Reports Filed by Christopher Aker

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 25 Jun 2025 13 $0 4 Sr. VP & General Counsel 27 Jun 2025, 17:06
RGLS Regulus Therapeutics Inc. 30 Jan 2025 1 $0 4 Sr. VP & General Counsel 31 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 13 Jan 2025 2 -$55,120 4 Sr. VP & General Counsel 15 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 09 Jan 2025 2 +$113,360 4 Sr. VP & General Counsel 10 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Sr. VP & General Counsel 21 May 2024, 16:20
RGLS Regulus Therapeutics Inc. 18 Jan 2024 1 -$6,510 4 Sr. VP & General Counsel 18 Jan 2024, 20:23
RGLS Regulus Therapeutics Inc. 12 Jan 2024 2 $0 4 Sr. VP & General Counsel 17 Jan 2024, 17:04
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 Sr. VP & General Counsel 14 Aug 2023, 17:12
RGLS Regulus Therapeutics Inc. 11 Jan 2023 1 $0 4/A Sr. VP & General Counsel 17 Jan 2023, 15:13
RGLS Regulus Therapeutics Inc. 10 May 2022 1 $0 4 Sr. VP & General Counsel 11 May 2022, 16:31
RGLS Regulus Therapeutics Inc. 12 Jan 2022 1 $0 4 Sr. VP & General Counsel 26 Jan 2022, 15:11
RGLS Regulus Therapeutics Inc. 17 May 2021 1 -$765 4 Sr. VP & General Counsel 17 May 2021, 19:12